Remedy Robotics
San Francisco developer of the N1, an AI-enabled robotic system for on-site, remote and autonomous endovascular procedures (investigational).
Remedy Robotics has raised $62M across 1 disclosed round since Nov 16, 2026; the latest round, Series B, was announced on Nov 16, 2026. Data as of Nov 17, 2026.
Headquartered in San Francisco, United States.
Latest from MEKAWIRE
Funding history
| Date | Round | Amount | Post-money valuation | Lead investor | Investors | Status | Source |
|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | Series B | $62M | — | DCVC | DCVCUC InvestmentsSkip CapitalHostplusHESTABioshoreOakwood Strategic CapitalCliffsBoost VCBuild CollectiveBlackbirdDivergent CapitalKdT Ventures | Official | Source |